Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study aims to clarify whether patients with chronic hepatitis B with high viral load
will benefit from oral antiviral therapy despite only mildly elevated serum liver enzyme.